Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis

Condition:   Sporadic Inclusion Body Myositis Interventions:   Drug: REGN2477+REGN1033;   Drug: Matching placebo Sponsor:   Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials